EI-2346, a novel interleukin-1beta converting enzyme inhibitor produced by Streptomyces sp. E-2346. I. Taxonomy of producing strain, fermentation, isolation, physico-chemical properties, and biological properties.
Clicks: 318
ID: 1072
2003
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
82.8
/100
314 views
253 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
EI-2346, a novel interleukin-1beta converting enzyme (ICE) inhibitor, was isolated from the culture broths of Streptomyces sp. E-2346. EI-2346 selectively inhibited the human recombinant ICE activity with an IC50 value of 3.9 microM, without inhibiting elastase and cathepsin B. EI-2346 also inhibited mature interleukin-1beta secretion from THP-1 cells induced by LPS with an IC50 value of 5.2 microM.
| Reference Key |
koizumi2003ei-2346,
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Koizumi, Fumito;Hasegawa, Atsuhiro;Ochiai, Keiko;Ando, Katsuhiko;Kondo, Hidemasa;Yoshida, Mayumi;Matsuda, Yuzuru;Nakanishi, Satoshi; |
| Journal | the journal of antibiotics |
| Year | 2003 |
| DOI |
DOI not found
|
| URL | URL not found |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.